ISIN
FR0014003XT0
Ticker
ALNFL
Sector
Sub-Industry
Country
France
Year Founded
2006
Making it possible to cure smoking addiction
NFL Biosciences develops a naturally based addiction withdrawal solution to help smokers willing to quit in their battle for a healthier life.
NFL Biosciences is a biotechnology company pioneering innovative solutions through a breakthrough approach based on a standardized extract of tobacco leaf. NFL-101 is NFL Biosciences current core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
Worldwide
FR0014003XT0
9695006VJWNTN4UNHA27
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.